Corbus Pharmaceuticals Holdings (CRBP) Other Non-Current Liabilities (2016 - 2023)

Corbus Pharmaceuticals Holdings' Other Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $44000.0 for Q4 2023.

• In Q4 2023, Other Non-Current Liabilities rose 98.15% year-over-year to $44000.0; the TTM figure through Dec 2023 stood at $44000.0 (up 98.15% YoY), while the FY2023 annual figure was $44000.0, up 98.15% from the prior year.
• Other Non-Current Liabilities was $44000.0 for Q4 2023 at Corbus Pharmaceuticals Holdings, down from $44410.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $2.5 million in Q1 2023 to a low of $797.0 in Q4 2020.
• Historically, Other Non-Current Liabilities has averaged $328741.7 across 4 years, with a median of $22205.0 in 2021.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities sank 97.23% in 2022, then surged 11258.73% in 2023.
• A 4-year view of Other Non-Current Liabilities shows it stood at $797.0 in 2020, then jumped by 2686.07% to $22205.0 in 2021, then changed by 0.0% to $22205.0 in 2022, then surged by 98.15% to $44000.0 in 2023.
• The last three Other Non-Current Liabilities figures came in at $44000.0 (Q4 2023), $44410.0 (Q3 2023), and $22205.0 (Q2 2023), per Business Quant data.